1. Anti-viral Immunity in the Tumor Microenvironment: Implications for the Rational Design of Herpes Simplex Virus Type 1 Oncolytic Virotherapy

   • Paul J. F. Rider
   • Ifeanyi K. Uche
   • Konstantin G. Kousoulas

   Microbial Anti-cancer Therapy and Prevention (PJF RIDER, L Sweeny AND KG KOUSOULAS, SECTION EDITORS) 26 November 2019 Pages: 193 - 199

2. Utilizing Microbes to Treat Naturally Occurring Cancer in Veterinary Species

   • Sita S. Withers
   • Ellen E. Sparger
   • Nicola J. Mason

   Microbial Anti-cancer Therapy and Prevention (PJF Rider, L Sweeny, and KG Kousoulas, Section Editors) 03 December 2019 Pages: 200 - 212

3. Listeria monocytogenes Cancer Vaccines: Bridging Innate and Adaptive Immunity

   • Zachary T. Morrow
   • Zachary M. Powers
   • John-Demian Sauer

   Microbial Anti-cancer Therapy and Prevention (PJF Rider, L Sweeny, and KG Kousoulas, Section Editors) 20 November 2019 Pages: 213 - 224

   

4. Salmonella Typhimurium as an Anticancer Therapy: Recent Advances and Perspectives

   • Katherine M. Broadway
   • Birgit E. Scharf

   Microbial Anti-cancer Therapy and Prevention (PJF Rider, L Sweeny, and KG Kousoulas, Section Editors) 20 November 2019 Pages: 225 - 239

   

5. Herpesvirus DNA Polymerase Mutants—How Important Is Faithful Genome Replication?

   • Jakob Trimpert
   • Nikolaus Osterrieder

   Virology (A Nicola, Section Editor) 23 November 2019 Pages: 240 - 248

   

6. Viral Genetic Diversity and Its Potential Contributions to the Development and Progression of Neonatal Herpes Simplex Virus (HSV) Disease

   • Lisa N. Akhtar
   • Moriah L. Szpara

   Virology (A Nicola, Section Editor) 23 November 2019 Pages: 249 - 256